Leprosy control has seen little innovation and only limited progress in the past decade.
However, research on the disease has increased and important innovations are underway …

With the worldwide implementation of WHO multidrug therapy in the 1980s, the global
burden of leprosy has decreased. However, the annual new case detection rate around the …

Background Every year more than 200,000 new leprosy cases are registered globally. This
number has been fairly stable over the past 8 years. WHO has set a target to interrupt the …

Background Worldwide, around 210,000 new cases of leprosy are detected annually. To
end leprosy, ie zero new leprosy cases, preventive interventions such as contact tracing and …

Background Leprosy control achieved dramatic success in the 1980s–1990s with the
implementation of short course multidrug therapy, which reduced the global prevalence of …

Tuberculosis (TB) and leprosy still represent significant public health challenges, especially
in low-and lower middle-income countries. Both poverty-related mycobacterial diseases …

Background Leprosy remains a public health problem in Brazil. Although the overall number
of new cases is declining, there are still areas with a high disease burden, such as Pará …

Leprosy (Hansen's disease) is an infectious, neglected tropical disease caused by the
bacterium or scientifically Mycobacterium Leprae (M. Leprae). Every year approximately …

India has the highest burden of leprosy in the world. Following a recent WHO guideline, the
Indian National Leprosy Programme is introducing post-exposure prophylaxis with single …

Background The Leprosy Post-Exposure Prophylaxis (LPEP) program explored the
feasibility and impact of contact tracing and the provision of single dose rifampicin (SDR) to …